OSK heads up at $125.52: long term Double Top? or break to Pop?
Updated
OSK just hit a double-fib at 125.42/52.
Both are Golden ratios (.618 multiples).
Could double top here or break and run.
.
"Double Top" as in the previous rejection exactly from this double fib:
Perhaps not exactly a double top since it had gone higher, but a major barrier nonetheless.
.
If it breaks the $125 fibs, it could run to $143-145 very quickly:
So this is a key level to watch and consider next actions.
=======================================================================================
.
Both are Golden ratios (.618 multiples).
Could double top here or break and run.
.
"Double Top" as in the previous rejection exactly from this double fib:
Perhaps not exactly a double top since it had gone higher, but a major barrier nonetheless.
.
If it breaks the $125 fibs, it could run to $143-145 very quickly:
So this is a key level to watch and consider next actions.
=======================================================================================
.
Comment
Pullback as expected Zoom in (m15) with some notes
Early, the Ping on Genesis fib tried to go anotehr leg.
but failed and We just bounced with a Ping on a Covid fib.
So we have fresh confirmations of BOTH fibs set,
so our zones dictated by confluences are still good:
We might get a little bounce here, but
we should wait for one of the green supports.
=======================================================================================
.
Trade active
Another top NAILED by fibs:
(yellow shaded area is after posting time).
.
Note the many clean reactions at pour zones:
Some not-so-clean on this tf, but on m1 we had clean pings.
.
Looks like correction might be done.
Time to start buying small dips again.
==================================================================
.
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.